Our research and development activities are organized in programs corresponding to a drug candidate or family of drug candidates targeting a given cell receptor. Successive phases are distinguished in carrying out a program, defined in reference to milestones M0 to M3.
The milestone following milestone M3 is the first marketing authorization.
| M0 ► |
M1 ► |
M2 ► |
M3 ► |
| initial definition of a program |
selection of a drug candidate and an indication |
first administration to humans | first clinical efficacy data in humans (proof of concept) |